Total medical devices industry cross border M&A deals worth $1.5bn were announced globally in Q3 2022, led by Azenta’s $468.22m acquisition of B Medical Systems, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 46.4% over the previous quarter of $2.78bn and a drop of 70.8% when compared with the last four-quarter average, which stood at $5.1bn.
Comparing cross border M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $1.05bn. At the country level, the Luxembourg topped the list in terms of deal value at $468.22m.
In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe top country in terms of cross border M&A deals activity in Q3 2022 was the US with 12 deals, followed by Germany with five and the UK with four.
In 2022, at the end of , cross border M&A deals worth $5.82bn were announced globally in medical devices industry, marking an increase of 68.7% year on year.
Cross Border M&A deals in medical devices industry in Q3 2022: Top deals
The top five cross border M&A deals in medical devices industry accounted for 68.7% of the overall value during Q3 2022.
The combined value of the top deals stood at $1.21bn, against the overall value of $1.5bn recorded for the quarter.
The top five medical devices industry cross border medical devices deals of Q3 2022 tracked by GlobalData were:
1) Azenta’s $468.22m acquisition deal with B Medical Systems
2) The $243.32m acquisition of Medi-Globe by DCC Healthcare
3) The $176m merger deal with NewSight Imaging and Vision Sensing Acquisition
4) The $170m acquisition of Curiosity Diagnostics by Bio-Rad Laboratories
5) Halma’s $154.02m acquisition deal with IZI Medical Products
